KYMR
Price
$30.17
Change
+$0.04 (+0.13%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
2.05B
71 days until earnings call
OLMA
Price
$5.17
Change
+$0.16 (+3.19%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
347.58M
82 days until earnings call
Interact to see
Advertisement

KYMR vs OLMA

Header iconKYMR vs OLMA Comparison
Open Charts KYMR vs OLMABanner chart's image
Kymera Therapeutics
Price$30.17
Change+$0.04 (+0.13%)
Volume$9.5K
Capitalization2.05B
Olema Pharmaceuticals
Price$5.17
Change+$0.16 (+3.19%)
Volume$12.85K
Capitalization347.58M
KYMR vs OLMA Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. OLMA commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and OLMA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (KYMR: $30.13 vs. OLMA: $5.01)
Brand notoriety: KYMR and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 82% vs. OLMA: 55%
Market capitalization -- KYMR: $2.05B vs. OLMA: $347.58M
KYMR [@Biotechnology] is valued at $2.05B. OLMA’s [@Biotechnology] market capitalization is $347.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, OLMA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while OLMA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • OLMA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than OLMA.

Price Growth

KYMR (@Biotechnology) experienced а +1.28% price change this week, while OLMA (@Biotechnology) price change was +11.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

OLMA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.05B) has a higher market cap than OLMA($348M). OLMA YTD gains are higher at: -14.065 vs. KYMR (-25.106). OLMA has higher annual earnings (EBITDA): -135.54M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. OLMA (215M). OLMA has less debt than KYMR: OLMA (1.7M) vs KYMR (86.3M). KYMR has higher revenues than OLMA: KYMR (58.9M) vs OLMA (0).
KYMROLMAKYMR / OLMA
Capitalization2.05B348M588%
EBITDA-232.67M-135.54M172%
Gain YTD-25.106-14.065178%
P/E RatioN/AN/A-
Revenue58.9M0-
Total Cash463M215M215%
Total Debt86.3M1.7M5,079%
TECHNICAL ANALYSIS
Technical Analysis
KYMROLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FITGX21.66N/A
N/A
Fidelity Advisor International Growth M
CLPCX12.13N/A
N/A
Catalyst Nasdaq-100 Hedged Equity C
WISNX13.63-0.01
-0.07%
William Blair International Sm Cap Gr N
HFETX54.75-0.10
-0.18%
Janus Henderson European Focus T
RTSAX36.06-1.04
-2.80%
Russell Inv Tax-Managed US Mid&Sm Cap A

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-4.17%
CCCC - KYMR
64%
Loosely correlated
-8.11%
RCKT - KYMR
58%
Loosely correlated
-3.80%
RVMD - KYMR
57%
Loosely correlated
-4.27%
IMNM - KYMR
56%
Loosely correlated
-7.48%
NRIX - KYMR
56%
Loosely correlated
-3.55%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-1.38%
RCKT - OLMA
51%
Loosely correlated
-3.80%
KYMR - OLMA
48%
Loosely correlated
-4.17%
IDYA - OLMA
48%
Loosely correlated
-2.45%
CRSP - OLMA
48%
Loosely correlated
-5.76%
NTLA - OLMA
48%
Loosely correlated
-4.86%
More